Design
Review
Answers are grounded in this paper and cite their sources.
Reinforces hypertriglyceridemia consideration in ASCVD risk assessment; leaves open need for targeted outcome trials.
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death and it has been confirmed that increased low density lipoprotein cholesterol (LDL-C) is an independent risk factor for atherosclerosis. Recently, the increasing evidence has showed that hypertriglyceridemia is associated with incremental ASCVD risk. But the proatherogenic mechanism of triglyceride (TG) remains unclear. Therefore, this article focuses on the clinical studies and proatherogenic mechanism related to hypertriglyceridemia, in order to provide reference for the prevention and treatment of ASCVD.
No takes yet. Share an insight, caveat, or question.
Peng et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: